Shkreli Martin

CIK 00015253542 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001525354

Recent Transactions

50 trades

Sale
HUMANIGEN, INC
Common Stock
2016-08-26$3.10/sh−309,723→ 0 total
Sale
HUMANIGEN, INC
Common Stock
2016-08-25$3.10/sh−1,913,206→ 309,723 total
Purchase
HUMANIGEN, INC
Common Stock
2015-11-24$38.15/sh+5,000→ 2,075,200 total
Purchase
HUMANIGEN, INC
Common Stock
2015-11-20$18.88/sh+5,000→ 2,070,200 total
Purchase
HUMANIGEN, INC
Common Stock
2015-11-18$2.02/sh+440,000→ 2,065,200 total
Purchase
HUMANIGEN, INC
Common Stock
2015-11-17$2.43/sh+7,000→ 1,625,200 total
Purchase
HUMANIGEN, INC
Common Stock
2015-11-17$1.93/sh+606,677→ 1,618,200 total
Purchase
HUMANIGEN, INC
Common Stock
2015-11-16$0.61/sh+500,169→ 914,254 total
Purchase
HUMANIGEN, INC
Common Stock
2015-11-16$1.43/sh+97,269→ 1,011,523 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-11-21$8.41/sh−252,847→ 1,765,168 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-11-20$8.23/sh−134,354→ 2,018,015 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-11-19$8.54/sh−329,824→ 2,152,369 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-11-18$9.19/sh−254,975→ 2,482,193 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-11-17$9.41/sh−100,000→ 2,737,168 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-11-14$10.23/sh−100,000→ 2,837,168 total
Other
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-10-02+332,980→ 2,995,148 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-10-01$0.01/sh−300,000→ 2,662,168 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-10-01$8.11/sh+25,000→ 2,962,168 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-09-30$9.42/sh+4,000→ 2,937,168 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-09-22$10.82/sh+35,000→ 2,933,168 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-09-19$11.78/sh+18,000→ 2,898,168 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-09-17$11.46/sh+6,000→ 2,880,168 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-09-16$10.69/sh+7,500→ 2,874,168 total
Other
Travere Therapeutics, Inc.$TVTX
Prepaid Forward Contract (obligation to sell)
2014-09-12+205,000→ 205,000 total
Other
Travere Therapeutics, Inc.$TVTX
Prepaid Forward Contract (obligation to sell)
2014-09-09+123,000→ 123,000 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-03-24$17.61/sh+4,000→ 2,941,380 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-03-20$17.97/sh+5,000→ 2,937,380 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-03-19$18.44/sh+3,500→ 2,932,380 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-03-14$17.36/sh+4,000→ 2,928,880 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-03-11$19.47/sh+25,900→ 2,924,880 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-03-10$19.32/sh+10,700→ 2,898,980 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-03-07$18.26/sh+2,498→ 2,888,280 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-03-06$18.93/sh+1,560→ 2,885,782 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-03-05$18.48/sh+4,000→ 2,884,222 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-02-28$18.67/sh+43,000→ 2,880,222 total
Award
Travere Therapeutics, Inc.$TVTX
Employee Stock Option (Right to Buy)
2014-02-24+200,000→ 200,000 total
Award
Travere Therapeutics, Inc.$TVTX
Employee Stock Option (Right to Buy)
2014-02-24+100,000→ 100,000 total
Award
Travere Therapeutics, Inc.$TVTX
Employee Stock Option (Right to Buy)
2014-02-24+100,000→ 100,000 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-02-21$17.20/sh+100→ 2,837,222 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-02-21$17.56/sh+1,600→ 2,837,122 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-02-14$14.60/sh+3,500→ 2,835,522 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-02-06$9.92/sh+2,000→ 2,832,022 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2014-01-14$10.84/sh+8,000→ 2,830,022 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2013-12-31$7.00/sh+150,000→ 2,816,246 total
Award
Travere Therapeutics, Inc.$TVTX
Employee Stock Option (Right to Buy)
2013-12-16+1,080,000→ 1,080,000 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2013-12-09$8.11/sh+100→ 2,666,246 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2013-12-06$8.30/sh+100→ 2,666,146 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2013-11-26$6.81/sh+150→ 2,666,046 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2013-11-22$6.06/sh+300→ 2,665,896 total
Purchase
Travere Therapeutics, Inc.$TVTX
Common Stock
2013-09-12$4.50/sh+5,556→ 2,665,596 total

Companies

Recent Filings

Address

777 THIRD AVENUE, 22ND FLOOR

NEW YORK, NY, 10017

View on SEC.gov